Saltbush - 36987-3419-4 - (Saltbush)

Alphabetical Index


Drug Information of Saltbush

Product NDC: 36987-3419
Proprietary Name: Saltbush
Non Proprietary Name: Saltbush
Active Ingredient(s): .05    g/mL & nbsp;   Saltbush
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Saltbush

Product NDC: 36987-3419
Labeler Name: Nelco Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102192
Marketing Category: BLA
Start Marketing Date: 19720829

Package Information of Saltbush

Package NDC: 36987-3419-4
Package Description: 50 mL in 1 VIAL, MULTI-DOSE (36987-3419-4)

NDC Information of Saltbush

NDC Code 36987-3419-4
Proprietary Name Saltbush
Package Description 50 mL in 1 VIAL, MULTI-DOSE (36987-3419-4)
Product NDC 36987-3419
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Saltbush
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19720829
Marketing Category Name BLA
Labeler Name Nelco Laboratories, Inc.
Substance Name ATRIPLEX WRIGHTII POLLEN
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Saltbush


General Information